Literature DB >> 12857582

Reliability and validity of the multiple sclerosis quality of life inventory in older individuals.

Terry Dilorenzo1, June Halper, Mary Ann Picone.   

Abstract

PURPOSE: Despite the increasing number of older individuals with multiple sclerosis (MS), there is a paucity of research on this subpopulation. Health-related quality of life (HRQOL) has received extensive attention in MS; however samples tend to be young. The present study assesses the internal consistency reliability and construct validity of the MS Quality of Life Inventory (MSQLI), a widely employed measure of HRQOL, in older individuals.
METHOD: Select subscales of the MSQLI and other measures of mental health and physical functioning were administered by telephone to 30 randomly selected older ( >or= 60) individuals and a gender-matched sample of younger ( < 60) individuals. Reliability estimates were calculated separately for each group. Construct (convergent) validity was assessed by examining the pattern of correlations between MSQLI subscales and measures of related constructs in the two groups.
RESULTS: Reliability estimates were similar in the two groups. With few exceptions, the correlations measuring convergent validity were in the expected direction, and of considerable magnitude, in both groups.
CONCLUSIONS: Results provide preliminary evidence that the MSQLI is a reliable and valid instrument for use with older individuals. The slightly different pattern of results observed in the validity analysis might be explained by an adjustment hypothesis. Future research on HRQOL in this subpopulation is encouraged.

Entities:  

Mesh:

Year:  2003        PMID: 12857582     DOI: 10.1080/0963828031000122195

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  8 in total

1.  Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis.

Authors:  Bo Young Yoon; Joo-Hyun Lee; So Young Shin
Journal:  Rheumatol Int       Date:  2017-09-04       Impact factor: 2.631

2.  Relationship between perceived cognitive dysfunction and objective neuropsychological performance in persons with rheumatoid arthritis.

Authors:  So Young Shin; Patricia Katz; Laura Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

Review 3.  Quality of life in multiple sclerosis.

Authors:  Józef A Opara; Krystyna Jaracz; Waldemar Brola
Journal:  J Med Life       Date:  2010 Oct-Dec

4.  Tablet-based screening improves continence management in multiple sclerosis.

Authors:  Heidi N Beadnall; Kushi E Kuppanda; Annmaree O'Connell; Todd A Hardy; Stephen W Reddel; Michael H Barnett
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

5.  Psychometric properties of modified MOS social support survey 5-item (MSSS-5-item) among Iranian older adults.

Authors:  Maryam Bakhshandeh Bavarsad; Mahshid Foroughan; Nasibeh Zanjari; Zahra Jorjoran Shushtari; Gholamreza Ghaedamini Harouni
Journal:  BMC Geriatr       Date:  2021-07-02       Impact factor: 3.921

6.  Levels and Rates of Physical Activity in Older Adults with Multiple Sclerosis.

Authors:  Rachel E Klaren; Emerson Sebastiao; Chung-Yi Chiu; Dominique Kinnett-Hopkins; Edward McAuley; Robert W Motl
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

7.  Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.

Authors:  Robert W Motl; Yvonne C Learmonth; Thomas R Wójcicki; Jason Fanning; Elizabeth A Hubbard; Dominique Kinnett-Hopkins; Sarah A Roberts; Edward McAuley
Journal:  BMC Geriatr       Date:  2015-12-03       Impact factor: 3.921

8.  Feasibility study design and methods for a home-based, square-stepping exercise program among older adults with multiple sclerosis: The SSE-MS project.

Authors:  Emerson Sebastião; Edward McAuley; Ryosuke Shigematsu; Robert W Motl
Journal:  Contemp Clin Trials Commun       Date:  2017-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.